Riskpilot← Back to searchSign inGet full accessHOV BIOVARME AS
ASActiveOrg 998349656Hovsbakken 8, 2860 HovProduction of electricity from renewable sources · NACE 3512Est. 20170 employees
Revenue 2024
NOK 1,5M
-11% vs 2023
EBITDA margin
36.8%
-17% vs 2023
Equity ratio
32.6%
Financial strength
Net profit 2024
NOK 834
-99% vs 2023
| Revenue | NOK 1,5M | -11% |
| EBITDA | NOK 551K | -17% |
| Net profit | NOK 834 | -99% |
| Total assets | NOK 5,8M | -1% |
| Equity | NOK 1,9M | +0% |
| Employees | 0 | — |
Legal name
HOV BIOVARME AS
Org number
998349656
Legal form
Aksjeselskap
NACE code
3512 · Production of electricity from renewable sources
Founded
31. januar 2017
Share capital
NOK 1 986 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Bygge og drifte bioenergianlegg, herunder levere energi fra anlegg og drive handel med flis av trevirke, samt alt som står i forbindelse med dette og investeringer og deltakelse i andre selskaper.
Address
Hovsbakken 8, 2860 Hov
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 328 | 1 130 | 1 429 | 1 689 | 1 499 |
| Staff expenses | −83 | −39 | −39 | −39 | −44 |
| EBITDA | 39 | 540 | 635 | 663 | 551 |
| Depreciation & amort. | −71 | −283 | −286 | −286 | −283 |
| EBIT | −32 | 257 | 349 | 377 | 268 |
| Net financials | −164 | −202 | −219 | −270 | −267 |
| Profit before tax | −196 | 55 | 130 | 107 | 1 |
| Tax | 42 | −0 | −0 | −0 | −0 |
| Net profit | −281 | 55 | 130 | 107 | 1 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 615 | 6 626 | 5 986 | 5 869 | 5 798 |
| Equity | 1 598 | 1 653 | 1 783 | 1 890 | 1 891 |
| Long-term debt | 4 800 | 4 559 | 3 939 | 3 719 | 3 499 |
| Short-term debt | 1 217 | 414 | 264 | 259 | 407 |
| Total debt | 6 017 | 4 973 | 4 203 | 3 979 | 3 907 |
EBITDA margin
36.8%
This company
15.8%
Market median
+133% vs market
20202024
Equity ratio
32.6%
This company
38.2%
Market median
+15% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.1%
This company
8.1%
Market median
-99% vs market
20202024
Asset turnover
0.26×
This company
1.12×
Market median
-77% vs market
20202024
Debt / equity
2.07×
This company
0.62×
Market median
-234% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 30.21% | 30.21% | 2023 | |
| Individual | 3.63% | 3.63% | 2023 | |
| Individual | 3.63% | 3.63% | 2023 | |
| Individual | 3.63% | 3.63% | 2022 | |
| Individual | 3.32% | 3.32% | 2023 | |
| Individual | 3.32% | 3.32% | 2023 | |
| Individual | 3.32% | 3.32% | 2023 | |
| Individual | 3.32% | 3.32% | 2023 | |
| Company | 3.32% | 3.32% | 2023 | |
| Individual | 3.17% | 3.17% | 2023 | |
| Individual | 3.17% | 3.17% | 2023 | |
| Individual | 3.17% | 3.17% | 2023 | |
| Individual | 3.02% | 3.02% | 2023 | |
| Company | 3.02% | 3.02% | 2023 | |
| Individual | 2.42% | 2.42% | 2023 | |
| Individual | 2.27% | 2.27% | 2023 | |
| Individual | 1.96% | 1.96% | 2023 | |
| Individual | 1.66% | 1.66% | 2022 | |
| Individual | 1.66% | 1.66% | 2023 | |
| Individual | 1.66% | 1.66% | 2023 | |
| Individual | 1.66% | 1.66% | 2023 | |
| Individual | 1.66% | 1.66% | 2024 | |
| Individual | 1.66% | 1.66% | 2023 | |
| Individual | 1.51% | 1.51% | 2023 | |
| Individual | 1.51% | 1.51% | 2023 | |
| Individual | 1.51% | 1.51% | 2023 | |
| Individual | 1.51% | 1.51% | 2023 | |
| Company | 1.51% | 1.51% | 2023 | |
| Company | 1.51% | 1.51% | 2023 | |
| Individual | 1.51% | 1.51% | 2023 | |
| Individual | 1.51% | 1.51% | 2022 | |
| Individual | 1.51% | 1.51% | 2023 | |
| Individual | 1.51% | 1.51% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Kistefos Skog As
HOV BIOVARME AS Board members of HOV BIOVARME AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|